3rdPartyFeeds

Buy Uber Stock Before Q2 Earnings Despite Early Disappointment?

The question is should investors consider buying Uber stock before it reports its second-quarter financial results even though the ride-hailing technology company has struggled as a public firm after its insane pre-IPO hype? Read More...

Shares of Uber UBER have fallen over 9% since reports came out on July 29 that it would cut hundreds of marketing jobs. The ride-hailing firm also saw its stock price sink over 3% Friday as the broader market fell following President Trump’s new Chinese tariffs announcement.  

Now the question is should investors consider buying Uber stock before it reports its second-quarter financial results even though the technology firm has struggled as a public firm after its insane pre-IPO hype?

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Recent News ” data-reactid=”13″>Recent News

News broke earlier this week that Uber cut roughly 400 jobs from its marketing department. The firm eliminated around a third of its marketing unit, as it deals with increased competition and price wars. “Put simply, we need to get our edge back. Being fast wins,” Uber CEO Dara Khosrowshahi wrote in an email to employees. “Many of our teams are too big, which creates overlapping work.”

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="What Investors Need to Know ” data-reactid=”15″>What Investors Need to Know

Uber is clearly trying to do all it can to show Wall Street and investors that it is committed to cost-cutting measures as it fights off rival Lyft LYFT and others. Many voiced their concern after Uber posted a $1.03 billion loss from operations in its first quarter as a public company. This figure came in far worse than the year-ago period’s $478 million loss, as it spent more heavily on everything from advertising to headcount.

Overall Q1 revenue did climb 20% from $2.58 billion to $3.09 billion. However, many growth-minded investors likely anticipated faster expansion. Plus, Uber’s adjusted (minus some payments to drivers and other costs) core platform revenue, which comes from ride-hailing and delivery, popped only 10% to $2.62 billion. In the prior-year period, this key metric soared roughly 80%.

Meanwhile, Uber’s core platform contribution margin fell from +17.9% in Q1 2018 to -4.5%. Investors need to pay close attention to this decline as it could signal that Uber will continue to lose more money as it pulls in more revenue, since the figure basically describes Uber’s profit margins from every ride-hailing trip or Uber Eats delivery.

 

 

 

 

Uber reports its business in two key segments: Core Platforms and Other Bets, which includes freight and more. In the long-run, the ride-hailing firm hopes it can become the Uber of everything and has compared itself to giants like Amazon AMZN. But as well-funded startups push into markets around the world, Uber could face a much harder time than many might have assumed a few years ago. This has, as we mentioned, ratcheted up the price wars, which has made profits more elusive.

Luckily, Uber’s Monthly Active Platform Consumers jumped 33% to 93 million, with trips up 36%. The company also currently operates in 63 countries and 700+ cities and boasts that its 3.9 million drivers, who are independent contractors, complete 14 million trips every day.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Q2 Outlook &amp; Beyond” data-reactid=”32″>Q2 Outlook & Beyond

Our current Zacks Consensus Estimates call for Uber to post second-quarter revenue of $3.41 billion. This would come in 10.3% higher than Q1 2019’s $3.09 billion, which marked 20% year-over-year expansion. Meanwhile, the company’s full-year fiscal 2019 revenue is projected to climb 27.5% to reach $14.36 billion. Peeking further ahead, Uber’s top line is expected to reach $19.26 billion in fiscal 2020, which would mark 34% expansion from our 2019 estimate.

At the bottom end of the income statement, Uber is projected to report an adjusted quarterly loss of -$3.33 per share. Last quarter, Uber posted a loss of $2.26 a share, which came in slightly better than our estimate that called for -$2.32. For the full year, Uber is expected to post a loss of -$6.07 per share, with a loss of -$3.00 a share predicated in 2020.  

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Bottom Line” data-reactid=”39″>Bottom Line

Uber stock opened its first official day of trading on May 10 at $42.00 a share. Shares of the ride-hailing giant have climbed as high as $47.08 since then, but hovered down 3.01% through late afternoon trading Friday at $40.07 a share. Uber’s underwhelming performance, especially compared to IPO star Beyond Meat BYND, might help it more easily impress investors when it reports its Q2 results after the market closes on Thursday, August 8.  

With this in mind, investors who can handle some risk might consider making a small bet that Uber can show some signs of strength that could help its stock pop. Others should wait to see how Wall Street reacts and then jump on some shares if it provides stronger-than-projected guidance, or other more promising metrics.

And let’s not simply write off the company’s long-term hopes to become an autonomous transportation powerhouse.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now&gt;&gt;” data-reactid=”43″>Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
&nbsp;
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
&nbsp;
Uber Technologies, Inc. (UBER) : Free Stock Analysis Report
&nbsp;
Lyft, Inc. (LYFT) : Free Stock Analysis Report
&nbsp;
Beyond Meat, Inc. (BYND) : Free Stock Analysis Report
&nbsp;
To read this article on Zacks.com click here.
&nbsp;
Zacks Investment Research” data-reactid=”44″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
 
Uber Technologies, Inc. (UBER) : Free Stock Analysis Report
 
Lyft, Inc. (LYFT) : Free Stock Analysis Report
 
Beyond Meat, Inc. (BYND) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Read More

Add Comment

Click here to post a comment